|
|
| Research article summary (published 30 Mar 2003): |
Pharmacological findings contribute to the understanding of the main physiological mechanisms of memory retrieval.
Full Abstract
Recent pharmacological findings have shown that retrieval of one-trial avoidance learning requires glutamate receptors, cAMP-dependent protein kinase and mitogen-activated protein kinases in the hippocampus, entorhinal, posterior parietal and anterior cingulate cortex. It requires AMPA but not other type of glutamate receptors or the protein kinases in the amygdala. Retrieval is modulated by dopamine D1, beta-noradrenergic, serotonin 1A and cholinergic receptors in the four cortical structures mentioned, and by beta-noradrenergic receptors in the basolateral amygdala. Further, retrieval is also modulated by peripheral ACTH, glucocorticoids, vasopressin, beta-endorphin and catecholamines; these hormones probably act through beta-noradrenergic receptor systems in the basolateral amygdala. Exposure to novelty or the systemic administration of antidepressant drugs prior to retention tests enhances retrieval, even for very remote memories. The effect of novelty is mediated by molecular mechanisms similar to those of retrieval itself.
Learn Faster Today Improve your study skills
Author information
Author/s: Barros, Daniela M (DM); Izquierdo, Luciana A (LA); Medina, Jorge H (JH); Izquierdo, Ivan (I);
Affiliation: Centro de Memória, Departamento de Bioquímica, Instituto de Ciencias Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcellos, 2600-anexo, 90035-003 Porto Alegre, RS, Brazil.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal: Current drug targets. CNS and neurological disorders (Curr Drug Targets CNS Neurol Disord), published in Netherlands. (Language: eng)
Reference: 2003-Apr; vol 2 (issue 2) : pp 81-94
Dates: Created 2003/05/28; Completed 2003/06/17; Revised 2006/11/15;
PMID: 12769801, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.
30 Oct 2007 - Harnessing hypoxic adaptation to prevent, treat, and repair stroke.
26 Nov 2007 - Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
3 Dec 2007 - Professor's little helper.
18 Dec 2007 - Improving outcome after stroke: overcoming the translational roadblock.
20 Feb 2008 - Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories.
9 Jan 2008 - Effect of brain DHA levels on cytoskeleton expression.
30 Dec 2007 - Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women.
30 Mar 2008 - A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
31 Mar 2008 - Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.
12 Apr 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.